Application of antisense oligonucleotide technology in the nervous system stands apart, largely because of its enormous success. The source of this success remains a matter of some controversy. This work addresses the origins of that controversy and determines whether the nervous system is a privileged site for antisense oligonucleotide action.
nl
en
